LTIP354A - Heterobicyclic compounds - Google Patents

Heterobicyclic compounds

Info

Publication number
LTIP354A
LTIP354A LTIP354A LTIP354A LTIP354A LT IP354 A LTIP354 A LT IP354A LT IP354 A LTIP354 A LT IP354A LT IP354 A LTIP354 A LT IP354A LT IP354 A LTIP354 A LT IP354A
Authority
LT
Lithuania
Prior art keywords
group
meanings
compounds
heterobicyclic compounds
so2nh
Prior art date
Application number
LTIP354A
Other languages
Lithuanian (lt)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Rodolfo Testa
Original Assignee
Recordati S.A. Chemical And Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI920408A external-priority patent/IT1254469B/en
Application filed by Recordati S.A. Chemical And Pharmaceutical Company filed Critical Recordati S.A. Chemical And Pharmaceutical Company
Publication of LTIP354A publication Critical patent/LTIP354A/en
Publication of LT3038B publication Critical patent/LT3038B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Abstract

Čia atskleisti junginiai, kurių bendra formulė@@@@@@@Geriau, kai heteroatomu X yra deguonis, bet gali būti ir kitos reikšmės.Geriau, kai grupė W yra karbonilo grupė, bet gali būti ir kitos reikšmės.Iš heterociklinių žiedųpirmenybė teikiama 4-okso-4H-1-benzopirano žiedui.Jis gali turėti daug R1, R2, R6 ir R7 pakitų. Yyra jungiamoji grupė, pasirinkta iš didelės eilės, į kurią įeina -COO-, -CONH-, -O-, -SO2- ir -SO2NH-, Z yra alkeleno grandinė, o B-kompleksinis aminas. Šie junginiai ir jų provaistai, enentiomerai, diastereoizomerai, N-oksidai ir farmaciškai tinkamos druskos tinka padidėjusio kraujospūdžio ir šlapimo trakto sutrikimų, susijusių su lengva prostatine hipertrofija ir kitų ligų gydymui.It is preferred that the compounds represented by the formula @ @@@@@@@ is preferably oxygen, but there may be other meanings. Better when the group W is a carbonyl group, but there may be other meanings. The preference of the heterocyclic rings is 4 -Oxo-4H-1-benzopyran ring. It may have many R 1, R 2, R 6 and R 7 substituents. Y is a linking group selected from the group consisting of -COO-, -CONH-, -O-, -SO2-, and -SO2NH-, Z is an alkylene chain, and a B-complex amine. These compounds and their prodrugs, enantiomers, diastereoisomers, N-oxides and pharmaceutically acceptable salts are suitable for the treatment of hypertension and urinary tract disorders associated with mild prostatic hypertrophy and other diseases.

LTIP354A 1992-02-25 1993-02-24 Heterobicyclic compounds LT3038B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI920408A IT1254469B (en) 1992-02-25 1992-02-25 BENZOPYRANIC AND BENZOTHIOPYRANIC DERIVATIVES
US07/888,775 US5403842A (en) 1992-02-25 1992-05-26 Benzopyran and benzothiopyran derivatives

Publications (2)

Publication Number Publication Date
LTIP354A true LTIP354A (en) 1994-04-25
LT3038B LT3038B (en) 1994-09-25

Family

ID=26330842

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP354A LT3038B (en) 1992-02-25 1993-02-24 Heterobicyclic compounds

Country Status (25)

Country Link
EP (1) EP0558245A1 (en)
JP (1) JPH069606A (en)
AU (2) AU3629693A (en)
BG (1) BG61946B1 (en)
CA (1) CA2090156A1 (en)
CZ (1) CZ205994A3 (en)
DZ (1) DZ1666A1 (en)
EE (1) EE03177B1 (en)
EG (1) EG20333A (en)
FI (1) FI943876A (en)
HR (1) HRP930210A2 (en)
HU (1) HUT72448A (en)
IL (1) IL104824A (en)
LT (1) LT3038B (en)
LV (1) LV10099B (en)
MX (1) MX9300977A (en)
NO (1) NO943140L (en)
NZ (1) NZ245995A (en)
PL (1) PL175556B1 (en)
SG (1) SG65570A1 (en)
SI (1) SI9300094A (en)
SK (1) SK280143B6 (en)
TW (1) TW382628B (en)
WO (1) WO1993017007A1 (en)
ZA (1) ZA931278B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300312A (en) * 1992-01-23 1993-07-31 Pfizer BENZOPYRANIC AND RELATED ANTAGONISTS OF LTB.
FR2689127B1 (en) * 1992-03-31 1994-05-06 Adir Cie NEWS 3 ', 5' -DITERTBUTYL-4'-HYDROXY FLAVONES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IT1266582B1 (en) * 1993-07-30 1997-01-09 Recordati Chem Pharm (DI) AZACYLO-HEXANIC AND DIAZACYLO-HEPTANIC DERIVATIVES
GB9317071D0 (en) * 1993-08-17 1993-09-29 Univ Strathclyde Flavonoids
KR100327270B1 (en) * 1994-01-14 2002-08-01 닛뽕쇼지가부시끼가이샤 Diazacycloalkynealkylsulfonamide derivative
FR2717175B1 (en) * 1994-03-11 1996-06-14 Adir New alkylaminoindane compounds, processes for their preparation and pharmaceutical compositions containing them.
IL112764A0 (en) * 1994-03-18 1995-05-26 Ferrer Int New chromene derivatives
ES2101620B1 (en) * 1994-03-18 1998-04-01 Ferrer Int NEW COMPOUND DERIVED FROM CHROMENE.
ATE203012T1 (en) * 1994-03-30 2001-07-15 Zeria Pharm Co Ltd 4-INDOL-1-YL-BUTTERIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS INHIBITORS FOR ALPHA1-ADRENERGIC RECEPTORS AND TESTOSTERONE 5ALPHA-REDUCTASES
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
DE4425146A1 (en) * 1994-07-15 1996-01-18 Basf Ag Use of heterocyclic compounds
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method
EP0757986B1 (en) * 1995-02-28 2002-06-12 Suntory Limited Arylpiperidine and arylpiperazine derivatives and drugs containing the same
GB9507288D0 (en) * 1995-04-07 1995-05-31 Sod Conseils Rech Applic Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors
EP0748800B1 (en) * 1995-06-09 2001-05-09 F. Hoffmann-La Roche Ag Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists
US5859014A (en) * 1995-06-09 1999-01-12 Syntex (U.S.A.) Inc. Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists
JPH0967367A (en) * 1995-06-23 1997-03-11 Suntory Ltd Thiopyran derivative
WO1997014419A1 (en) * 1995-10-20 1997-04-24 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
IT1282705B1 (en) * 1996-02-28 1998-03-31 Recordati Chem Pharm USE OF 5-HT | A SEROTONINERGIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US6063810A (en) * 1996-03-08 2000-05-16 Synthelabo 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
FR2745815B1 (en) * 1996-03-08 1998-06-26 Synthelabo BENZOFURANE DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
CN1227550A (en) * 1996-08-22 1999-09-01 赫彻斯特马里恩鲁斯公司 Troponyl piperazines as selective dopamine D4 receptor ligands
AU2002300904B2 (en) * 1997-05-12 2004-12-23 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
PL192596B1 (en) 1997-05-12 2006-11-30 Ortho Mcneil Pharm Inc Aryl-substituted piperazines useful in treating bph
JP3476475B2 (en) 1997-06-04 2003-12-10 株式会社アズウェル Method for producing piperazine sulfonamide derivative and salt thereof
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives
US6306861B1 (en) 1999-07-30 2001-10-23 Recordati S.A. Chemical And Pharmaceutical Company Thienopyrancecarboxamide derivatives
US6387909B1 (en) 1999-07-30 2002-05-14 Recordati S.A. Chemical And Pharmaceutical Company Thienopyranecarboxamide derivatives
IT1313581B1 (en) * 1999-07-30 2002-09-09 Recordati Chem Pharm TIENOPIRANCARBOSSAMIDICI DERIVATIVES.
DE19941657A1 (en) * 1999-09-01 2001-03-08 Schwabe Willmar Gmbh & Co Cinnamic acid nitriles, process for their preparation and use
US6403594B1 (en) 1999-10-18 2002-06-11 Recordati, S.A. Chemical And Pharmaceutical Company Benzopyran derivatives
IT1314192B1 (en) * 1999-10-18 2002-12-06 Recordati Chem Pharm BENZOPYRANIC DERIVATIVES
JP2002113006A (en) 2000-10-10 2002-04-16 Toshiba Medical System Co Ltd Method of setting for diagnostic apparatus, and diagnostic instrument
CN1150176C (en) 2002-05-22 2004-05-19 上海医药工业研究院 Aralkylone pipeazine derivative and its application
JP2006511500A (en) * 2002-10-30 2006-04-06 メルク　エンド　カムパニー　インコーポレーテッド γ-Aminoamide-based chemokine receptor activity modulator
BRPI0511834A (en) 2004-07-14 2008-01-08 Ptc Therapeutics Inc methods for treating hepatitis c
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1781289A1 (en) 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridines for treating hepatitis c
CN101120002A (en) 2005-02-17 2008-02-06 惠氏公司 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
KR101679089B1 (en) * 2008-09-29 2016-11-23 서트리스 파마슈티컬즈, 인코포레이티드 Chromenone analogs as sirtuin modulators
CZ2012242A3 (en) 2012-04-10 2013-09-04 Univerzita Palackého Use of copper complexes containing 2-phenyl-3-hydroquinolin-4(1H)-one and derivatives of 1,10-fenanthrolin for preparing medicaments intended for treating tumor diseases
ES2880766T3 (en) 2016-02-09 2021-11-25 Pharmakea Inc Quinolinone lysyl oxidase inhibitors similar to type 2 and uses thereof
WO2020095912A1 (en) * 2018-11-06 2020-05-14 第一三共株式会社 Benzimidazole derivative
EP4058425A4 (en) * 2019-11-11 2023-11-22 Southwest Research Institute Recrystallized hi-6 dimethylsulfate
WO2021113627A1 (en) 2019-12-06 2021-06-10 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
TW202313593A (en) 2021-06-04 2023-04-01 美商維泰克斯製藥公司 N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
TW202334089A (en) 2021-11-02 2023-09-01 美商夫雷爾醫療公司 Pparg inverse agonists and uses thereof
CN115160279B (en) * 2022-07-27 2023-11-24 中国药科大学 Benzopyrone compounds, pharmaceutical compositions and uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
GB1156973A (en) 1965-07-06 1969-07-02 Quinazoline Derivatives
DE2123923A1 (en) * 1971-05-14 1972-11-23 Boehringer Mannheim Gmbh, 6800 Mannheim Square bracket on omega- (Flavon-7yl-oxy) -alkyl Square bracket on -pigerazine derivatives and process for their preparation
NZ200981A (en) 1981-07-17 1984-10-19 Recordati Chem Pharm 3-methylflavone-8-carboxylic acid derivatives and pharmaceutical compositions
JPS60202872A (en) * 1984-03-27 1985-10-14 Kaken Pharmaceut Co Ltd Benzofuran derivative, its preparation, and hypotensive agent containing said derivative as active component
US4678787A (en) * 1985-01-30 1987-07-07 Warner-Lambert Company 4H-1-benzopyran-4-ones and their sulfur containing analogs
JPS63139180A (en) * 1986-12-02 1988-06-10 Tanabe Seiyaku Co Ltd Carboxylic acid derivative
IL87451A0 (en) * 1987-09-04 1989-01-31 Tanabe Seiyaku Co Benzofuran derivatives,their preparation and pharmaceutical compositions containing them
US5278174A (en) * 1990-06-04 1994-01-11 Scios Nova, Inc. Sigma binding site agents

Also Published As

Publication number Publication date
EE03177B1 (en) 1999-04-15
NZ245995A (en) 1994-09-27
AU3629693A (en) 1993-09-13
SK280143B6 (en) 1999-09-10
LV10099B (en) 1995-02-20
TW382628B (en) 2000-02-21
SK100794A3 (en) 1995-04-12
CZ205994A3 (en) 1995-02-15
BG98990A (en) 1995-05-31
HU9402443D0 (en) 1994-10-28
EG20333A (en) 1998-10-31
HUT72448A (en) 1996-04-29
AU3377393A (en) 1993-08-26
CA2090156A1 (en) 1993-08-26
BG61946B1 (en) 1998-10-30
IL104824A0 (en) 1993-06-10
JPH069606A (en) 1994-01-18
IL104824A (en) 1999-12-22
FI943876A0 (en) 1994-08-23
DZ1666A1 (en) 2002-02-17
LT3038B (en) 1994-09-25
FI943876A (en) 1994-08-23
SI9300094A (en) 1993-09-30
ZA931278B (en) 1993-11-18
EP0558245A1 (en) 1993-09-01
NO943140D0 (en) 1994-08-25
LV10099A (en) 1994-05-10
WO1993017007A1 (en) 1993-09-02
AU660067B2 (en) 1995-06-08
MX9300977A (en) 1993-12-01
NO943140L (en) 1994-08-25
PL175556B1 (en) 1999-01-29
SG65570A1 (en) 1999-06-22
HRP930210A2 (en) 1995-06-30

Similar Documents

Publication Publication Date Title
LTIP354A (en) Heterobicyclic compounds
ATE313535T1 (en) PYRAZINYL-PIPERAZINE COMPOUNDS, THEIR APPLICATION AND PRODUCTION
NO943877L (en) Inhibition of smooth muscle cell proliferation and restenosis
ATE165830T1 (en) DIHYDRO PYRAZOLOPYRROLES
RU94043324A (en) Heterobicyclic compounds
EA199800141A1 (en) HETEROCYCLIC COMPOUNDS
DE69628019D1 (en) CHINOLONES AND THEIR THERAPEUTIC USE
DE69106365T2 (en) CHINUCLIDINE DERIVATIVES.
NO864474D0 (en) NEW 4-BENZYL-1- (2H) -FTHALAZINON DERIVATIVES.
NZ329532A (en) Diazepino-indoles as phosphodiesterase iv inhibitors
ATE205199T1 (en) QUINOLINE OR QUINAZOLINE DERIVATIVES, THEIR PRODUCTION AND USE
DE69323712T2 (en) INDOL DERIVATIVES FOR TREATING MIGRAINE
ATE213731T1 (en) QUINOXALINE DERIVATIVES AND THEIR THERAPEUTIC USES
DE69300318D1 (en) Flavone derivatives.
NO20052854L (en) Substituted alkyl pyridazinones for the treatment of memory and learning failure.
GEP19981432B (en) Bicyclic Heterobicyclic Derivatives
YU13093A (en) BICYCLIC HETEROCYCLIC DERIVATIVES

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20000224